EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A new digital droplet PCR method for looking at epigenetics in diffuse large B ‐cell lymphomas: The role of BMI1 , EZH2 , and USP22 genes

Alessio Lusci Gemignani, Robel Papotti, Riccardo Bomben, Valter Gattei, Samantha Pozzi, Valentina Donati, Stefania Bettelli, Elisa Forti, Giovanna Mansueto, Arianna Di Napoli, Maria Christina Cox, Leonardo Flenghi und 8 weitere

International Journal of Laboratory Hematology · 2025

DOI: 10.1111/ijlh.14363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2025. Verfasst von Alessio Lusci Gemignani und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Polycomb Repressive Complex 1, Enhancer of Zeste Homolog 2 Protein, Epigenesis, Genetic. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Rock & Peace foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Epigenetics has been shown to be relevant in oncology: BMI1 overexpression has been reported in leukemias, EZH2 mutations have been found in follicular lymphoma, and USP22 seems to stabilize BMI1 protein. In this study, we measured the expression of BMI1, EZH2 , and USP22 in lymph nodes from 56 diffuse large B‐cell lymphoma (DLBCL) patients.

Methods

A new multiplex digital droplet PCR (ddPCR) has been set up to measure the expression of 4 genes ( BMI1, EZH2, USP22 , and GAPDH ) in the same reaction on RNA extracted from paraffin‐embedded tissues.

Results

The specificity of ddPCR was confirmed by a 100% alignment on the BLAST platform and its repeatability demonstrated by duplicates. A strict correlation between expression of BMI1 and EZH2 and BMI1 and USP22 has been found, and high expression of these genes was correlated with extra‐nodal lymphomas. Progression‐free survival (PFS) and overall survival (OS) were conditioned by IPI, bone marrow infiltration, and the complete response achievement. High levels of BMI1 and USP22 did not condition the response to therapy, but impaired the PFS, especially for patients defined at “high risk” based on the cell of origin (no germinal center [GCB]), high BCL2 expression, and IPI 3‐5. In this subgroup, the probability of relapse/progression was twice higher than that of patients carrying low BMI1 and USP22 levels.

Conclusion

High expression of BMI1 and of USP22 might be a poor prognostic factor in DLBCL, and might represent the target for novel inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffusePolycomb Repressive Complex 1Enhancer of Zeste Homolog 2 ProteinEpigenesis, GeneticUbiquitin ThiolesterasePolymerase Chain ReactionHumansMaleFemaleMiddle AgedAgedAdultGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

BMI1DLBCLEZH2USP22ddPCR

Substanzen

Polycomb Repressive Complex 1BMI1 protein, humanEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanUsp22 protein, humanUbiquitin Thiolesterase

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • International PhD School in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Università di Modena e Reggio Emilia, Modena, Italy.
  • Pathology II, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Patologia Molecolare e Medicina Predittiva, AOU Modena, Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Università di Modena e Reggio Emilia, Modena, Italy.

ORCID-Profile: Sara Galimberti

Förderung

  • Rock & Peace foundation

Zitieren

APA

Lusci Gemignani, A., Papotti, R., Bomben, R., Gattei, V., Pozzi, S., Donati, V., Bettelli, S., Forti, E., Mansueto, G., Di Napoli, A., Cox, M. C., Flenghi, L., Rossi, P., Volpe, G., Dardanis, D., Bono, C., Guerrini, F., Morganti, R., Sacchi, S., & Galimberti, S. (2025). A new digital droplet PCR method for looking at epigenetics in diffuse large B ‐cell lymphomas: The role of BMI1 , EZH2 , and USP22 genes. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14363

Vancouver

Lusci Gemignani A, Papotti R, Bomben R, Gattei V, Pozzi S, Donati V, et al. A new digital droplet PCR method for looking at epigenetics in diffuse large B ‐cell lymphomas: The role of BMI1 , EZH2 , and USP22 genes. International Journal of Laboratory Hematology. 2025. doi:10.1111/ijlh.14363

BibTeX
@article{LusciGemignani2025,
  author = {Lusci Gemignani, Alessio and Papotti, Robel and Bomben, Riccardo and Gattei, Valter and Pozzi, Samantha and Donati, Valentina and Bettelli, Stefania and Forti, Elisa and Mansueto, Giovanna and Di Napoli, Arianna and Cox, Maria Christina and Flenghi, Leonardo and Rossi, Pietro and Volpe, Guido and Dardanis, Dimitri and Bono, Clara and Guerrini, Francesca and Morganti, Riccardo and Sacchi, Stefano and Galimberti, Sara},
  title = {A new digital droplet PCR method for looking at epigenetics in diffuse large B ‐cell lymphomas: The role of BMI1 , EZH2 , and USP22 genes},
  journal = {International Journal of Laboratory Hematology},
  year = {2025},
  doi = {10.1111/ijlh.14363}
}
Kostenlos starten →